National Eye Health Week 2023; IbisVision is furthering technology for the future of eye care

Wed 13th September 2023

IbisVision has developed an advanced online platform with a suite of best in class products and exams, allowing eye care professionals to provide the best possible service to patients and customers. Our dedication to creating greater accessibility in eye care has driven us to work with some forward-thinking leaders across both the optometry and healthcare sectors.

To support awareness throughout National Eye Health Week (NEHW), we are highlighting some of our work with these leaders, in particular the NHS as one of the key discussion themes over the next few days, as well as sharing more on how our technology can be utilised as an early detection tool.

Since 2021, IbisVision has been working with NHS Forth Valley to develop a remote vision screening platform solution that could integrate into wider NHS services and Ophthalmic patient pathways. Our work in Forth Valley and further afield has allowed us to focus on the provisions for children’s eye care to ensure clinicians can provide accessible, flexible and convenient eye care to as many children as possible so they can receive regular check-ups. As well as this, it has allowed us to look into and explore how our technology could become part of the solution in stroke assessments within NHS communities.

IbisVision’s NHS projects have led to us being able to explore our online testing platform further and plan for how we can continue to make advancements in our technology for the future of eye care. NEHW is an important week for reflecting on some of the issues at hand and with myopia becoming an ongoing cause for concern as well as access to NHS eye care services, IbisVision is well poised to help in raising awareness with our interlinked purposes and continued support of the NHS.

To find out more about our online platform, IBIS-Connect and features including online refraction, a suite of online eye exams and live video consultations, click here.